Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 3.1 EX-3.1
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 10.7 EX-10.7
- 10.8 EX-10.8
- 10.9 EX-10.9
- 10.10 EX-10.10
- 10.11 EX-10.11
- 10.12 EX-10.12
- 10.13 EX-10.13
- 10.14 EX-10.14
- 10.15 EX-10.15
- 10.16 EX-10.16
- 10.17 EX-10.17
- 23.3 EX-23.3
- 23.4 EX-23.4
- 23.5 EX-23.5
- 23.6 EX-23.6
- 99.1 EX-99.1
- 99.2 EX-99.2
Vidara Therapeutics International Public similar filings
Filing view
External links
Exhibit 23.4
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-4 of Vidara Therapeutics International Limited and related prospectus/proxy statement of our report dated March 13, 2014 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in Horizon Pharma, Inc.’s Annual Report on Form10-K for the year ended December 31, 2013. We also consent to the reference to us under the heading “Experts” in such Registration Statement and related prospectus/proxy statement.
/s/ PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP
Chicago, Illinois
June 26, 2014